Skip to main content
. Author manuscript; available in PMC: 2010 Aug 10.
Published in final edited form as: J Med Chem. 2007 Aug 16;50(18):4493–4500. doi: 10.1021/jm070569b

Figure 4.

Figure 4

Effects of doxorubicin and doxazolidine on decatenation of KDNA (kinetoplast DNA) by topoisomerase II. Lane 1, KDNA without topoisomerase II (catenated form); lane 2, KDNA with topoisomerase II (decatenated form); lane 3, doxorubicin, 500 nM; lane 4, doxorubicin, 50 nM; lane 5, doxazolidine, 500 nM; lane 6, doxazolidine, 50 nM. C: catenated DNA; N: nicked, decatenated DNA; R: relaxed, decatenated DNA.